Welcome to Newomics - Innovation Integration

Newomics Inc., an early stage biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare.

 
 

Technologies



Mass spectrometry is the enabling technology for proteomics. To fully realize the enormous potential of lab-on-a-chip in proteomics.
Read More...

Products



Services



 
 

News & Events

2016.05.02

Newomics announces that it has been awarded an NIH SBIR Phase II grant totaling $1.5 million
Read more...


2016.04.19

Newomics’ Biomonitoring Chip paper has been selected as one of the ES&T’s Best Papers of 2015 for environmental technology.
Read more...


2016.01.22

Newomics announces that it has been awarded two NIH SBIR Phase II grants totaling $3.0 million.
Read more...


2015.06.08

C&EN of the American Chemical Society highlighted our publication on microchip blood test.
Read more...